España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Fulgent Genetics
FLGT
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$16.90
0.04
0.24%
At close: -
$16.90
0.00
0.00%
After Hours: Feb 14, 4:00 PM EDT
Get Report
Comment
Q4 2024 Earnings in 12 days from now on Fri Feb 28th, before the market open
Fulgent Genetics (FLGT) Forecast
News
Earnings
Fulgent Genetics (FLGT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Fulgent Genetics (NASDAQ:FLGT) Stock
Fulgent Genetics Stock (NASDAQ: FLGT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, February 04, 2025
Foundation Medicine Announced U.S. Launch Of ...
Benzinga Newsdesk
Monday, November 11, 2024
Piper Sandler Maintains Neutral on Fulgent Ge...
Benzinga Newsdesk
Friday, November 08, 2024
Fulgent Genetics Raises FY24 Adj EPS Guidance...
Benzinga Newsdesk
Fulgent Genetics Q3 2024 Adj. EPS $0.31 Beats...
Benzinga Newsdesk
Thursday, November 07, 2024
Uncovering Potential: Fulgent Genetics's Earnings Preview
Benzinga Insights
Thursday, October 31, 2024
Fulgent Genetics Awarded Contract By The U.S....
Benzinga Newsdesk
Friday, August 02, 2024
Fulgent Genetics Expect 2024 Core Revenue Of ...
Benzinga Newsdesk
Fulgent Genetics Q2 2024 Adj. EPS $0.15 Beats...
Benzinga Newsdesk
Friday, May 24, 2024
Fulgent To Present Clinical Data For Its Lead...
Benzinga Newsdesk
Friday, May 03, 2024
Fulgent Forecasts 2024 Core Revenue Of Approx...
Benzinga Newsdesk
Fulgent Genetics Q1 2024 Adj EPS $(0.01) May ...
Benzinga Newsdesk
Wednesday, March 06, 2024
Piper Sandler Maintains Neutral on Fulgent Ge...
Benzinga Newsdesk
Wednesday, February 28, 2024
Fulgent Genetics shares are trading lower aft...
Benzinga Newsdesk
Fulgent Genetics Expects 2024 Core Revenue of...
Benzinga Newsdesk
Fulgent Genetics Q4 Adjusted EPS $0.28 May No...
Benzinga Newsdesk
Earnings Scheduled For February 28, 2024
Benzinga Insights
Friday, February 09, 2024
CooperSurgical Partners With Fulgent Genetics...
Benzinga Newsdesk
Thursday, December 07, 2023
UBS Initiates Coverage On Fulgent Genetics wi...
Benzinga Newsdesk
Friday, November 03, 2023
Fulgent Genetics shares are trading higher af...
Benzinga Newsdesk
Fulgent Sees FY23 Core Revenue $260M Vs $260....
Benzinga Newsdesk
Earnings Scheduled For November 3, 2023
Benzinga Insights
Fulgent Q3 2023 EPS $(0.39) Misses $(0.33) Es...
Benzinga Newsdesk
Thursday, November 02, 2023
Earnings Preview: Fulgent Genetics
Benzinga Insights
Monday, October 16, 2023
Piper Sandler Maintains Neutral on Fulgent Ge...
Benzinga Newsdesk
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Monday, October 02, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, September 29, 2023
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Thursday, September 28, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Friday, August 04, 2023
Why Is Fulgent Genetics Stock Moving Higher Today?
Vandana Singh
Fulgent Sees Q3 FY23 Sales Of Approximately $...
Benzinga Newsdesk
Fulgent Revises FY23 Revenue Guidance To $260...
Benzinga Newsdesk
Fulgent Genetics Q2 Adjusted EPS $(0.08) Beat...
Benzinga Newsdesk
Earnings Scheduled For August 4, 2023
Benzinga Insights
Thursday, August 03, 2023
Earnings Outlook For Fulgent Genetics
Benzinga Insights
Friday, May 19, 2023
Fulgent Genetics Earnings Perspective: Return On Capital Employed
Benzinga Insights
Friday, May 05, 2023
Fulgent Genetics shares are trading higher af...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Fulgent Genetics: Q1 Earnings Insights
Benzinga Insights
Fulgent Genetics Q1 Adjusted EPS $(0.22) Beat...
Benzinga Newsdesk
Earnings Scheduled For May 5, 2023
Benzinga Insights
Thursday, May 04, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Preview: Fulgent Genetics's Earnings
Benzinga Insights
Monday, April 03, 2023
5 Value Stocks To Watch In The Healthcare Sector
Benzinga Insights
Monday, March 06, 2023
Looking Into Fulgent Genetics's Return On Capital Employed
Benzinga Insights
Thursday, March 02, 2023
Credit Suisse Maintains Outperform on Fulgent...
Benzinga Newsdesk
Tuesday, February 28, 2023
Fulgent Genetics Sees Q1 Total Revenue $56M ...
Bill Haddad
Fulgent Genetics Q4 EPS $(0.48) Beats $(0.56) Estimate, Sales $67.70M Beat $59.57M Estimate
Bill Haddad
Earnings Scheduled For February 28, 2023
Benzinga Insights
Friday, January 06, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
